A new systematic review shows that nasal spray adrenaline (via liquid or powder sprays) can be as fast or faster than injections for treating anaphylaxis, a possible needle-free alternative to EpiPen®.
Dan Plev, Consultant Spinal Neurosurgeon at The London Clinic, discusses how sciatica can be treated with alternative methods when surgery isn't necessary.
Rachel Conant, Vice President Federal Affairs, Alzheimer’s Association and Alzheimer’s Impact Movement, provides us with an update on Alzheimer’s and dementia funding rises in the United States.
Kapil Bharti, PhD, Senior Investigator and Head of the Ocular and Stem Cell Translational Research Section at the National Eye Institute (NEI), explains testing the safety of a stem cell therapy for age-related macular degeneration in this special focus on eye health.
Dr Vincent Maida discusses his discoveries and pioneering research in the area of using Topical Cannabis-Based Medicines (TCBM) for integumentary and wound management.
Maria Piggin, Chair of PNH Support tells us about the rare disease, paroxysmal nocturnal haemoglobinuria (PNH) and in this area, collaborations for change.
Jessica Eagelton, co-chair of the Taskforce for lung Health Pulmonary Rehabilitation working group, discusses Pulmonary rehabilitation: a drug-free treatment that is changing the lives of people with lung disease.
Peter Jackson, Executive Director of the AMR Centre, describes new initiatives and partnerships that point the way forward for the UK’s antimicrobial resistance response.
As AI solutions are increasingly adopted in the healthcare sector, Dr Khalid Alyafei – Chief Medical Informatics Officer at Sidra Medicine in Qatar – discusses the benefits and challenges.
From big data to database rights, Sean Leach, UK & European Patent Attorney at Mathys & Squire, explains the role technology plays in the future of healthcare.
Eos Scientific has commissioned research across a sample of more than 2000 UK adults exploring the growing shift in health-conscious millennials seeking CBD oil over prescriptions for mental health.
A newly developed graphene-based implant can record electrical activity in the brain at extremely low frequencies and over large areas, unlocking the wealth of information found below 0.1 Hz and the potential for new epilepsy treatment.
Sam Mountney, Senior Policy & Campaigns Officer at Epilepsy Action, shares his expertise on cannabis-based medicines as a treatment for epilepsy in the UK.
